CSF3 and Stroke: In support of this, meta-analysis has demonstrated that G-CSF does not improve outcomes in stroke patients.148 A number of in vitro strategies have been used to drive the secretome towards a more desirable anti-inflammatory and pro-trophic phenotype including priming with pro-inflammatory cytokines, hypoxic preconditioning, biomaterials and 3D culture (Figure 1).